BlackRock’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-516,795
| Closed | -$11M | – | 5308 |
|
|
2024
Q1 | $11M | Buy |
516,795
+96,989
| +23% | +$2.07M | ﹤0.01% | 3248 |
|
|
2023
Q4 | $4.03M | Buy |
419,806
+411,553
| +4,987% | +$3.96M | ﹤0.01% | 3703 |
|
|
2023
Q3 | $21.5K | Hold |
8,253
| – | – | ﹤0.01% | 5063 |
|
|
2023
Q2 | $38.5K | Hold |
8,253
| – | – | ﹤0.01% | 5023 |
|
|
2023
Q1 | $31.1K | Hold |
8,253
| – | – | ﹤0.01% | 5107 |
|
|
2022
Q4 | $26K | Hold |
8,253
| – | – | ﹤0.01% | 5261 |
|
|
2022
Q3 | $25K | Hold |
8,253
| – | – | ﹤0.01% | 5388 |
|
|
2022
Q2 | $20K | Hold |
8,253
| – | – | ﹤0.01% | 5466 |
|
|
2022
Q1 | $64K | Sell |
8,253
-1,300
| -14% | -$10.1K | ﹤0.01% | 5288 |
|
|
2021
Q4 | $40K | Sell |
9,553
-404,703
| -98% | -$1.69M | ﹤0.01% | 5371 |
|
|
2021
Q3 | $3.28M | Sell |
414,256
-56,047
| -12% | -$444K | ﹤0.01% | 4058 |
|
|
2021
Q2 | $3.8M | Sell |
470,303
-337,233
| -42% | -$2.72M | ﹤0.01% | 3930 |
|
|
2021
Q1 | $8.66M | Sell |
807,536
-23,201
| -3% | -$249K | ﹤0.01% | 3607 |
|
|
2020
Q4 | $9.76M | Buy |
830,737
+370,819
| +81% | +$4.36M | ﹤0.01% | 3308 |
|
|
2020
Q3 | $5.53M | Buy |
459,918
+6,727
| +1% | +$80.9K | ﹤0.01% | 3439 |
|
|
2020
Q2 | $7.92M | Buy |
+453,191
| New | +$7.92M | ﹤0.01% | 3251 |
|